Literature DB >> 24415302

C242T polymorphism of NADPH oxidase p22phox gene reduces the risk of coronary artery disease in a random sample of Egyptian population.

Ingy M Hashad1, Mohamed F Abdel Rahman, Sahar M Abdel-Maksoud, Khalda S Amr, Laila K Effat, Gamal M Shaban, Mohamed Z Gad.   

Abstract

The p22phox protein subunit is essential for NADPH oxidase activity. The prevalence of C242T variants of p22phox gene was studied in 101 healthy Egyptian controls and 104 acute myocardial infarction (AMI) Egyptian patients. Contribution of oxidative stress, represented by serum oxidized-LDL (ox-LDL), in development of AMI was also examined and correlated with C242T gene variants. Genotyping and ox-LDL were assessed by PCR-RFLP and ELISA. Results showed that wild type CC genotype is prevalent in 27 % of controls; CT and TT are in 72 and 1 %. In patients, the distribution was 40.2, 59.8 and 0 % for CC, CT and TT; respectively, showing a significant difference (p = 0.0259). Serum ox-LDL levels were higher in patients than controls (p ≤ 0.0001). Subjects having CT genotype had lower levels of ox-LDL than CC genotype (p ≤ 0.005). C242T polymorphism of p22phox gene of NADPH oxidase is a novel genetic marker associated with reduced susceptibility to AMI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24415302     DOI: 10.1007/s11033-014-3081-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  38 in total

1.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Coronary artery superoxide production and nox isoform expression in human coronary artery disease.

Authors:  Tomasz J Guzik; Jerzy Sadowski; Bartlomiej Guzik; Andrew Jopek; Boguslaw Kapelak; Piotr Przybylowski; Karol Wierzbicki; Ryszard Korbut; David G Harrison; Keith M Channon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-17       Impact factor: 8.311

3.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease.

Authors:  N Inoue; S Kawashima; K Kanazawa; S Yamada; H Akita; M Yokoyama
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

Review 4.  NADPH oxidases in cardiovascular health and disease.

Authors:  Alison C Cave; Alison C Brewer; Anilkumar Narayanapanicker; Robin Ray; David J Grieve; Simon Walker; Ajay M Shah
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

Review 5.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

Authors:  Karen Bedard; Karl-Heinz Krause
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

6.  Angiotensin-converting enzyme and p22(phox) polymorphisms and the risk of coronary heart disease in a low-risk Spanish population.

Authors:  Trinidad Mata-Balaguer; Roberto de la Herrán; Carmelo Ruiz-Rejón; Manuel Ruiz-Rejón; Manuel A Garrido-Ramos; Fernando Ruiz-Rejón
Journal:  Int J Cardiol       Date:  2004-06       Impact factor: 4.164

7.  Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitro.

Authors:  C H Chen; H H Nguyen; D Weilbaecher; S Luo; A M Gotto; P D Henry
Journal:  Atherosclerosis       Date:  1995-08       Impact factor: 5.162

8.  Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway.

Authors:  M Katsura; L A Forster; G A Ferns; E E Anggård
Journal:  Biochim Biophys Acta       Date:  1994-07-14

9.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

Authors:  P Holvoet; J Vanhaecke; S Janssens; F Van de Werf; D Collen
Journal:  Circulation       Date:  1998-10-13       Impact factor: 29.690

10.  Plasma oxidized LDL: a predictor for acute myocardial infarction?

Authors:  G Nordin Fredrikson; B Hedblad; G Berglund; J Nilsson
Journal:  J Intern Med       Date:  2003-04       Impact factor: 8.989

View more
  7 in total

1.  Meta-analysis of C242T polymorphism in CYBA genes: risk of acute coronary syndrome is lower in Asians but not in Caucasians.

Authors:  Po Hu; Ming-yuan Huang; Xin-yang Hu; Xiao-jie Xie; Mei-xiang Xiang; Xian-bao Liu; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

2.  Relationship between C242T polymorphism and arterial stiffness in an apparently healthy population.

Authors:  Y Ji; J Ge; Z Zhu; F Wang; J Jiang; H Cao
Journal:  J Hum Hypertens       Date:  2015-10-15       Impact factor: 3.012

3.  Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome.

Authors:  J A Hubacek; V Staněk; M Gebauerová; R Poledne; M Aschermann; H Skalická; J Matoušková; A Kruger; M Pěnička; H Hrabáková; J Veselka; P Hájek; V Lánská; V Adámková; J Pitˇha
Journal:  Mol Biol Rep       Date:  2015-03-26       Impact factor: 2.316

4.  AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.

Authors:  Mina Amir; Sally I Hassanein; Mohamed F Abdel Rahman; Mohamed Z Gad
Journal:  Mol Biol Rep       Date:  2018-10-03       Impact factor: 2.316

Review 5.  Genetics of coronary artery disease and myocardial infarction.

Authors:  Xuming Dai; Szymon Wiernek; James P Evans; Marschall S Runge
Journal:  World J Cardiol       Date:  2016-01-26

Review 6.  Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus.

Authors:  Miha Tibaut; Daniel Petrovič
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2016

7.  Effect of C242T Polymorphism in the Gene Encoding the NAD(P)H Oxidase p22phox Subunit and Aerobic Fitness Levels on Redox State Biomarkers and DNA Damage Responses to Exhaustive Exercise: A Randomized Trial.

Authors:  Su-Youn Cho; Wi-Young So; Hee-Tae Roh
Journal:  Int J Environ Res Public Health       Date:  2020-06-12       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.